Non-Squamous Non-Small Cell Lung Cancer

4 total trials 2 recruiting

Filter these 4 trials by phase, country, sponsor and more.

Open in Search →

BEAMION Lung-2: A study to test whether zongertinib (BI 1810631) helps people with advanced non-small cell lung cancer with HER2 mutations c … Recruiting

2023-504308-27-00 5 2024-06-06
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination with Osimertinib as Firs … Recruiting

2024-518586-10-00 10 2025-09-18
Tuvusertib (M1774) in Combination with Cemiplimab in Participants with Non-Squamous NSCLC (DDRiver NSCLC 322) Recruitment ended

2022-502010-85-00 9 2023-12-20
BEVERLY: A randomized open-label phase 3 trial comparing bevacizumab + erlotinib vs erlotinib alone as first line treatment of patients with … Recruitment ended

2024-516843-15-00 5 2015-11-23

Showing 1–4 of 4 trials